Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
Clinical trial NCT04402073 · TERMINATED
Trial details
- NCT number
- NCT04402073
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-11
- Primary completion
- 2025-06-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.